Rentschler Biopharma SE is a leading contract development and manufacturing organization (CDMO) focused on the process development and manufacturing of biopharmaceuticals in mammalian cell lines. We provide an essential contribution to the availability of biopharmaceuticals and thereby help millions of people. Founded in 1927, Rentschler is a family-owned company, located in Laupheim, Germany and employing around 850 people.
As a full-service CDMO we support our global clients through to market approval of their products. The company’s clients include innovative biotech companies and major pharmaceutical companies around the world. Many years of experience and excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler’s high quality standards. The drive to develop novel effective solutions is deeply rooted in the Rentschler DNA. We are constantly evolving. This enables us to react quickly and effectively even to the most demanding client requirements.
What unites us at Rentschler Biopharma, is the passion for what we do. It is the fundamental basis for superior quality – and the drive within our entire process chain. Our corporate culture is characterized by a sense of responsibility, mutual respect and an open, communicative nature. This enables fast, efficient decisions and guarantees smooth-running processes.